Alerts will be sent to your verified email
Verify EmailSAKAR
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
9.28 % | 25.05 % | 20.61 % |
5yr average Equity Multiplier
|
1.75 | 2.22 | 1.17 |
5yr Average Asset Turnover Ratio
|
0.5 | 1.05 | 0.72 |
5yr Avg Net Profit Margin
|
10.38 % | 10.9 % | 24.8 % |
Price to Book
|
2.44 | 6.71 | 5.64 |
P/E
|
44.22 | 46.99 | 27.81 |
5yr Avg Cash Conversion Cycle
|
-14.29 Days | 26.94 Days | 79.85 Days |
Inventory Days
|
46.75 Days | 66.86 Days | 64.55 Days |
Days Receivable
|
51.16 Days | 128.09 Days | 100.92 Days |
Days Payable
|
103.34 Days | 163.91 Days | 74.04 Days |
5yr Average Interest Coverage Ratio
|
5.43 | 13.1 | 579.71 |
5yr Avg ROCE
|
10.08 % | 27.25 % | 25.27 % |
5yr Avg Operating Profit Margin
|
24.06 % | 18.45 % | 30.87 % |
5 yr average Debt to Equity
|
0.47 | 0.51 | 0.01 |
5yr CAGR Net Profit
|
3.94 % | 14.26 % | 16.28 % |
5yr Average Return on Assets
|
5.37 % | 11.52 % | 17.7 % |
Shareholdings
|
|||
Promoter Holding
|
53.58 % | 72.51 % | 70.56 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-13.96 % | -2.97 % | 1.67 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.36 % | 0.55 % |
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Wise Break-Up - API'S
|
Therapeutic Area Wise Break-Up - API'S
|
-
|
-
|